Alnylam Pharmaceuticals, Inc. (ALNY)

310.89 +2.46 (+0.80%) USD  |  NASDAQ  |  Apr 22, 15:05
More

Alnylam Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Pfizer Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Eli Lilly & Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade